Advanced Dialysis Center
Lanham, Maryland, 20706, United States
NCT Number: NCT00579202
The purpose of the study is to study the ease of use of the Polyflux HD-C4 Small dialyzer under conditions of routine clinical use for hemodialysis
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lanham, Maryland, 20706, United States
Market evaluation protocol.
This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy. This study is strictly aimed at obtaining feedback from the nursing and technical staff regarding the use of the Polyflux HD-C4 Small dialyzer. The dialysis nursing staff will complete ease of use assessments following routine dialysis therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Involves the use of FDA 510(k) cleared hemodialyzers and will have no impact on the patient's routine dialysis therapy.
Time frame: During priming of each dialyzer
Time frame: At the completion of each treatment
Vantive Health LLC
Industry
The Gambro Polyflux HD-C4 Small Ease of Use Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704008
Anxiety Disorders, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07334522
Agnosia, Anxiety
Karbala, Iraq
View Trial DetailsNCT06759376
Chronic Disease, Chronic Kidney Disease
Eskişehir, Turkiye, Turkey (Türkiye)
View Trial DetailsNCT07687498
Chronic Disease, Disease Attributes
Mersin, Yenişehir, Turkey (Türkiye)
View Trial Details